MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia with Lewy bodies (DLB)"

  • 2026 International Congress

    A novel pro-drug overcomes short-half life and absorption challenges and increase brain penetration of dopamine as a potential therapy for Parkinson’s disease

    C. Moussa (Washington DC, USA)

    Objective: We developed a new small molecule drug candidate that would increase the effectiveness of dopamine delivery to the brain. We also sought to mitigate…
  • 2026 International Congress

    Cortical–Subcortical Structural Signature of dementia with lewy bodies Reveals Cognitive Trajectories of Lewy Body Disease in REM Sleep Behavior Disorder

    JH. Shin, HJ. Kim, JY. Lee (Seoul, Democratic People's Republic of Korea)

    Objective: We aimed to derive a DLB-related structural MRI pattern based on cortical and subcortical morphometry and investigate whether this pattern predicts phenoconversion and clinical…
  • 2026 International Congress

    Amyloid Burden in the Precuneus and Posterior Cingulate Gyrus Is Associated With Cognitive Function and White Matter Microstructure in Lewy Body Dementia

    H. Takeshige-Amano, N. Nishikawa, M. Osawa, H. Okada, D. Kamiyama, K. Onuki, S. Takemoto, K. Takabayashi, K. Kamagata, K. Murakami, T. Kato, T. Hatano, N. Hattori (Tokyo, Japan)

    Objective: To investigate the relationship between amyloid burden measured by PET and white matter microstructural alterations assessed by advanced diffusion MRI in individuals with Parkinson’s…
  • 2026 International Congress

    The Syn-D Study: Detection of Longitudinal Changes in Cutaneous Phosphorylated Alpha-Synuclein in Mild Cognitive Impairment

    R. Freeman, T. Levine, J. Parent, S. Marcotte, B. Bellaire, M. Duval, C. Gibbons (Boston, USA)

    Objective: To quantify the deposition of cutaneous phosphorylated alpha-synuclein (P-SYN) and plasma P-Tau217 in patients with mild cognitive impairment (MCI) due to suspected Alzheimer’s disease…
  • 2026 International Congress

    Synergistic Impact of Plasma Neurofilament Light Chain and Neuroimaging Deficits on Cognitive Decline in Prodromal Lewy Body Disease

    K. Hiraga, D. Tamakoshi, T. Fukushima, Y. Saito, K. Fuse, T. Uematsu, T. Tsuboi, M. Sato, K. Yokoi, K. Suzuki, Y. Arahata, Y. Washimi, M. Yamamoto, H. Shimizu, M. Wakai, H. Tatebe, T. Tokuda, A. Nakamura, S. Niida, M. Katsuno (Nagoya, Japan)

    Objective: To assess the synergy between neuroimaging deficits and plasma biomarkers in predicting longitudinal cognitive and motor progression in individuals at high risk for prodromal…
  • 2026 International Congress

    Acrostic for the differential diagnosis of atypical Parkinsonian

    L. Ortega-Bolaños, V. Martinez-Villota, E. Gatto, D. Bolaños Ortega, K. Ortega Dorado, C. Hurtado Gonzalez, J. Fernandez Boccazzi (CALI, Colombia)

    Objective: Evaluating the usefulness of clinical acrostic for the differential diagnosis of atypical Parkinsonian syndromes Background: Differentiate Parkinson’s disease from atypical parkinsonian syndromes  is challenging…
  • 2026 International Congress

    Cross-Continental Differences in Prodromal Symptoms of Lewy Body Dementia: A Comparative Analysis Across Asia, Europe, and North America

    C. Hu, N. Nguyen (San Antonio, USA)

    Objective: To systematically analyze the prevalence of prodromal symptoms in Lewy Body Dementia (LBD) across different continents, focusing on REM sleep behavior disorder (RBD), hallucinations,…
  • 2026 International Congress

    Safety and Feasibility of Repetitive Transcranial Magnetic Stimulation in Dementia with Lewy Bodies: An Ongoing Proof-of-Concept Study

    K. Baik, M. Park (Seoul, Republic of Korea)

    Objective: To investigate the safety and potential cognitive benefits of repetitive transcranial magnetic stimulation (rTMS) in patients with dementia with Lewy bodies (DLB) using a…
  • 2026 International Congress

    The predictive value of the 18F-FDG PET-derived Parkinson’s disease Related Pattern for neurodegenerative disease progression in isolated REM Sleep Behavior Disorder

    A. Dortmond, S. Lövdal, G. Carli, K. Leenders, K. Reetz, S. Schawohl, D. Arnaldi, B. Orso, S. Morbelli, A. Janzen, W. Oertel, D. Perani, L. Ferini-Strambi, A. Galbiati, C. Liguori, A. Chiaravalloti, M. Carpi, J. Lee, R. Kim, S. Meles (Groningen, Netherlands)

    Objective: To determine whether baseline and longitudinal Parkinson’s disease–related pattern expression predicts conversion to Parkinson’s disease or dementia with Lewy bodies in idiopathic REM sleep…
  • 2026 International Congress

    Identification of Alpha-synuclein Pathology in Dementia with Lewy Body Participants by Seed Amplification Assay

    C. Farris, S. Weber, Y. Ma, M. Starke, B. Mollenhauer, L. Concha (San Diego, USA)

    Objective: To assess frequency and type of misfolded α-synuclein aggregates (syn-seeds) in cerebrospinal fluid (CSF) from dementia with Lewy bodies (DLB) participants by means of…
  • 1
  • 2
  • 3
  • …
  • 25
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley